Drug-Delivery Technology Market Is Expected To Offer Substantial Growth Opportunities, Reaching $91.4 Billion By 2030

What Is The Expected Valuation Of The Drug-Delivery Technology Market In The Upcoming Years, And How Quickly Is It Set To Grow?
The drug-delivery technology market size has grown rapidly in recent years. It will grow from $54.24 billion in 2025 to $60.27 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to growth in chronic diseases, advancements in pharmaceutical formulations, demand for improved patient compliance, expansion of injectable therapies, innovation in medical devices.

The drug-delivery technology market size is expected to see rapid growth in the next few years. It will grow to $91.41 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to rise of personalized medicine, increasing biologics and biosimilars, demand for long acting drug delivery, technological advances in implantables, growing home care treatment adoption. Major trends in the forecast period include targeted drug delivery systems, controlled and sustained release formulations, patient centric drug delivery devices, minimally invasive delivery technologies, advanced implantable drug systems.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23377&type=smp

Which Major Drivers Are Accelerating Expansion Within The Drug-Delivery Technology Market?
The increasing prevalence of chronic diseases is expected to propel the growth of the drug-delivery technology market. Chronic diseases refer to long-term medical conditions that typically progress slowly and require ongoing management. The increasing prevalence of chronic diseases is due to a sedentary lifestyle, which reduces physical activity and contributes to obesity and related health issues. Drug-delivery technology enhances chronic diseases by enabling targeted delivery, controlled release, improved bioavailability, and reduced side effects, ultimately improving treatment effectiveness, patient adherence, and disease management. For instance, in July 2024, according to the Australian Burden of Disease Study 2023 by the Australian Institute of Health and Welfare (AIHW), chronic conditions accounted for 91% of non-fatal burden (years lived with disability) and 78% of fatal burden (years of life lost) in 2023. Therefore, the increasing prevalence of chronic diseases is driving the growth of the drug-delivery technology market.

Which Segments Are Expected To Shape The Future Direction Of The Drug-Delivery Technology Market?
The drug-delivery technology market covered in this report is segmented –

1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications
3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users

Subsegments:
1) By Oral: Tablets, Capsules, Solutions, Suspensions, Powders, Gels
2) By Injectable: Conventional Injection, Self-Injection, Long-Acting Injection
3) By Topical: Creams, Gels, Lotions, Patches, Ointments
4) By Ocular: Eye Drops, Ointments, Gels, Inserts, Implants
5) By Nasal: Sprays, Drops, Powders, Gels
6) By Pulmonary: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
7) By Transmucosal: Buccal, Sublingual, Rectal, Vaginal
8) By Implantable: Biodegradable Implants, Non-Biodegradable Implants, Drug-Eluting Stents

Which Trends Are Reshaping Growth Within The Drug-Delivery Technology Market?
Major companies operating in the drug-delivery technology market are focusing on developing innovative products such as prefilled injection devices to enhance patient convenience, improve dosing accuracy, and ensure safer drug administration. A prefilled injection device is a medical device that comes preloaded with a specific dose of medication, eliminating the need for manual drug filling before administration. For instance, in February 2023, Phillips-Medisize LLC, a US-based medical equipment manufacturing company, launched a new disposable pen injector designed for high-volume manufacturing. The injector features a compact and flexible design with customizable dosing and push-button colors to support multiple therapies, including diabetes, fertility, growth hormones, obesity, and osteoporosis. The device aims to help pharmaceutical companies accelerate market entry by offering a cost-effective, ready-to-use solution while reducing commercialization costs and risks.

Who Are The Companies Setting The Competitive Benchmark In The Drug-Delivery Technology Market?
Major companies operating in the drug-delivery technology market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., and Circassia Pharmaceuticals Plc.

Get Your In-Depth Drug-Delivery Technology Market Report Now:
https://www.thebusinessresearchcompany.com/report/drug-delivery-technology-global-market-report

Which Region Currently Accounts For The Largest Share Of The Drug-Delivery Technology Market?
North America was the largest region in the drug-delivery technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-delivery technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

 

Comments

Post a Comment

Popular posts from this blog

Train And Components Market Report 2025 – Strategic Data for Growth and Expansion

Image
  Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the anticipated market size of the train and components industry over the next few years? The train and components market size has grown strongly in recent years. It will grow from $245.66 billion in 2024 to $266.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to economic conditions, urbanization, government investment, environmental concerns. The train and components market size is expected to see strong growth in the next few years. It will grow to $354.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to high-speed rail expansion, sustainable transport, electrification, freight rail expansion, regulatory compliance. Major trends in the forecast period include electrification and lightweighting, advan...
Read more

Facade Gasket Market Expected to Hit $2.17 Billion by 2029, Growing at 8.6% CAGR

Image
 Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations How Is the Facade Gasket Market Expected to Expand in Terms of Size and Growth? The facade gasket market size has grown strongly in recent years. It will grow from $1.43 billion in 2024 to $1.56 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing use of ethylene propylene diene monomer (EPDM) in construction, rising demand for weather-resistant materials, a rise in high-rise building developments, increasing focus on building envelope performance, and rising adoption of curtain wall systems. The facade gasket market size is expected to see strong growth in the next few years. It will grow to $2.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing government focus on sustainable infrastructure, risin...
Read more

Global Telecom Industry Outlook: Revenue and CAGR Projections to 2029

Image
Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence What Is the Growth Potential of the Telecom Market Size Over 2025-2034? The telecom market size has grown steadily in recent years. It will grow from $2914.96 billion in 2024 to $3048.49 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to growing number of internet users, increasing adoption of 5g networks and rise in adoption of cloud computing among smes (small and medium-sized enterprises). The telecom market size is expected to see strong growth in the next few years. It will grow to $3719.55 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rising smartphone penetration, increasing e-commerce, increasing urbanization and government initiatives will drive the growth. Major trends in the forecast period include focus on dep...
Read more